Feeds
Immunovaccine Inc. said Monday that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.
Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults.
Drug developer Pfizer Inc. said Friday the Food and Drug Administration approved an intravenous version of its high blood pressure drug Revatio.
Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals.
After drug giant Pfizer Inc. announced that it was opening a new research center here, city officials aggressively moved to acquire surrounding land for an economic development project — triggering an epic fight over eminent domain that reached the U.S. Supreme Court and ended with residents being forced from their homes.
Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often misleading, indicating the medicine worked better than internal company documents showed.
Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites:
Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations.
Drugmaker Pfizer Inc. said Thursday its shareholders will have input on compensation for company executives starting in 2010.
Pfizer Inc. said Wednesday it awarded bonuses of $1 million or more to two executives after completing its $68 billion purchase of former rival Wyeth.
Drugmaker Pfizer Inc. on Tuesday posted a 26 percent jump in third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales.
Megamergers in the pharmaceutical industry usually take many months to sort out, but the two research directors at newly combined Pfizer Inc. and Wyeth say they're off to a running start.
A subsidiary of Pfizer has been sentenced after pleading guilty to illegally promoting the pain killer Bextra.
Pfizer Inc. and Wyeth have tied the knot in the drug industry's most expensive marriage this year.
Pfizer Inc.'s $68 billion purchase of Wyeth will close Thursday after antitrust regulators in the U.S. and Canada cleared the deal, which will make Pfizer the world's largest drugmaker by revenue.
Federal health advisers said Thursday that Pfizer's HIV drug Selzentry should be approved for use by patients who have not already taken other drugs to combat the virus.
In the latest sign that Pfizer Inc.'s $68 billion purchase of Wyeth will go through, Wyeth's stock has been removed from two key investor indices.
Drug developer Pfizer Inc. said Tuesday China's ministry of commerce approved the company's $68 billion buyout of rival Wyeth.
A subsidiary of Pfizer has pleaded guilty to illegally promoting the pain killer Bextra.
Federal prosecutors hit Pfizer Inc. with a record-breaking $2.3 billion in fines Wednesday and called the world's largest drugmaker a repeating corporate cheat for illegal drug promotions that plied doctors with free golf, massages, and resort junkets.
Drugmaker Pfizer Inc. and the Nigerian government have resolved a long-running legal dispute over allegations children there were harmed in a 1996 Pfizer study of an experimental antibiotic during a meningitis outbreak.
Drug giant Pfizer Inc. on Wednesday said its second-quarter profit plunged 19 percent, as the strong dollar pulled down revenue, and higher taxes and costs for its pending purchase of Wyeth hurt the bottom line.
Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.
Pfizer Inc. is pulling a plan to staff a biotechnology research center in San Francisco and will keep its 100 area employees in South San Francisco.
Pfizer is discontinuing a late-stage study of its cancer drug Sutent (SOO-tent) as an initial treatment for colon cancer because the drug is not proving effective enough.
Alert: Pfizer's Prevnar Streptococcus Pneumoniae Vaccination Causes Death in the NetherlandsThe Dutch health institute RIVM has stopped the distribution of a batch of Pfizer's Prevnar childhood vaccine following the death of 3 babies shortly after being vaccinated.
Pfizer and Kelo's Ghost Town The Supreme Court's 2005 decision in Kelo v. City of New London stands as one of the worst in recent years, handing local governments carte blanche to seize private property in the name of economic development.
Pfizer To Shut Down Facilities; 600 To Lose JobsPLATTSBURGH, N.Y. -- "Things happen, things leave, things close. Whether it's an Air Force base, paper mill or pharmaceutical company, the mark of a community is how it responds," said Gary Douglas of the North Country Chamber of Commerce.
Pharma Giant Pfizer Shareholders Get to Vote on CEO PayPfizer shareholders will get to cast a non-binding "advisory vote" on the company's compensation packages for senior execs.
Grassley's NAMI Probe May Want to Look at Pfizer Whistleblower SuitSen. Charles Grassley is investigating the National Alliance for the Mentally Ill, the New York Times reports. He might want to look into Pfizer's $2.3 billion Bextra settlement as one of the suits within it made some juicy claims about how NAMI works.
Lawsuit Alleges Pfizer Used Bogus ResearchThe lawsuit, filed by Dr. Stefan Kruszewski of Harrisburg, Pa., alleges that three of the researchers who helped conduct Geodon clinical trials - Dr. Richard Borison, Dr. Bruce Diamond and Dr. Louis Fabre - have been sanctioned by regulatory authorities.
Betty McCollum vs. Michele Bachmann Smackdown: Treat Felonious Corporations At Least as Harshly as ACORN, Which Committed NoneTwo articles: Dem Rep: Treat Felonious Corporations At Least as Harshly as ACORN (Which Committed None) (with video)
Medicare Covers Transplants, But Limits Payments for Anti-Rejection Drugs - NYTimes.comSad and weird story about Medicare's 36 month cut off for anti rejection drugs needed after kidney transplant. It is also very interesting look into the like of those dealing with the health care crisis.
In Pfizer's Cancer Battle, Profit But Little ProgressPfizer's fortunes in the past were built on cardiovascular drugs, like the cholesterol buster Lipitor and the blood pressure pill Norvasc.
Pfizer pays $55 million to Texas for Medicaid fraudTexas, a coalition of other states Texas and the U.S. Department of Justice have resolved a lengthy civil Medicaid fraud investigation into Pfizer Inc. the recovered more than $1 billion for state Medicaid programs and several federal programs.
Puff! Puff! Gotta stop smoking. It's not healthy. The doctor says a new product will do the trick. It's called Chantix. OMG! It costs $122. No takeout and forget going for drinks with friends. This is important. My health takes precedence.
FDA Approves First-Ever Dog Cancer Drug (Video)Nine-year-old Stella is a beautiful mixed breed with a loving family.
Free Viagra for the unemployed, says PfizerFREE Viagra for the unemployed! Pharmaceutical company Pfizer earned this catchy headline this week with its plans to make 70 products free to US residents who have lost their job.
Study: Viagra & Cialis Do Not Harm VisionReuters reports that a study funded by Pfizer and Eli Lilly & Company has found that men who took Viagra or Cialis daily for six months did not develop any significant vision problems.
AT LAST, Pfizer brought to heel over Nigerian drug trial deaths; to pay $75 millionA full 12 years ago, Pfizer tested the drug Trovan in the middle of a triple epidemic in Nigeria. It did not tell the human guinea pigs that it was a drug trial. This was clearly unethical. But Pfizer fought to deny Nigerians the right to sue in an American court.
Wyeth CEO gets $10m award NEW YORK - US drugmaker Wyeth, which is slated to merge with Pfizer Inc later this year, has granted chief executive Bernard Poussot US$10.25 million (S$15.87 million) as a 2009 long-term incentive award and approved multi-million dollar awards to other senior executives.
Claim: LeCarre's "The Constant Gardener" Was Based on Pfizer Trovan CaseThe Connecticut Law Tribune claims that The Constant Gardener, a John Le Carré book and later a movie with the same name, is in fact based on the Pfizer Trovan case.
Stealth Advertising: The reason the drug's name is not mentioned in the commercial and, no, you probably won't like it.Help-seeking ads can come in handy for drugs that have a particularly nasty list of side effects, since not mentioning the drug by name means you don't have to list the side effects either, according to the U.S Food and Drug Administration.
Will Pfizer-Wyeth Deal Bump Chief Justice From Preemption Case?As readers of the LB know, one of the top cases of the current Supreme Court term is Wyeth v. Levine, which asks whether a state law tort action challenging the labeling on a Wyeth drug is pre-empted by federal law.
Pfizer to disclose payments to doctors next year - Business Wire - News & ObserverIt's regrettable that it is the threat of legislation that would actually pass this year prompts this sudden disclosure. Call me a cynic, but I cannot celebrate Pfizer or any of these pharmaceutical companies for doing what they should.
Nigerians can sue US drugs firmNigerian families can sue the Pfizer drugs giant in the US over its alleged role in the deaths of children, a US appeals court has ruled. The decision overturns ruling by a lower court that the case must be heard in Nigeria.
Pfizer to acquire Wyeth for $68 billionThe board of Pfizer, the world's largest drug maker, has agreed to acquire a rival, Wyeth, for $68 billion, the companies announced Monday.
Major U.S. Companies to Slash 43,000 Jobs - washingtonpost.comAmerican companies announced job cuts totaling 43,000 this morning, as the global downturn slammed the profits of exporters like Caterpillar and a domestic recession hit hard at retailer Home Depot.
Pfizer Agrees to $68 Billion Deal for Wyeth The board of Pfizer, the world's largest drug maker, agreed on Sunday night to acquire a rival, Wyeth, for $68 billion, according to people involved in the negotiations.
Pfizer in talks to buy Wyeth NEW YORK/PHILADELPHIA - PFIZER Inc, the world's largest drugmaker, is in talks to buy Wyeth in a deal possibly valued at more than US$60 billion (S$90 billion), sources familiar with the situation said on Friday, sending Wyeth shares up 12.8 per cent.
Log In | Register
